Data as of Nov 25
| -0.16 / -3.95%|
The 3 analysts offering 12-month price forecasts for Sorrento Therapeutics Inc have a median target of 11.00, with a high estimate of 35.00 and a low estimate of 9.00. The median estimate represents a +182.78% increase from the last price of 3.89.
The current consensus among 3 polled investment analysts is to Buy stock in Sorrento Therapeutics Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.